MedPath

Impact of Ketogenic Diets in Preventing Relapse in Obesity Management

Not Applicable
Completed
Conditions
Obesity
Interventions
Behavioral: Isocaloric balanced weight loss maintenance diet
Behavioral: Ketogenic weight loss maintenance diet
Registration Number
NCT04382183
Lead Sponsor
Norwegian University of Science and Technology
Brief Summary

Low-carb ketogenic diets have become extremely popular because of large weight loss in the short-term. Yet their potential benefits in preventing long-term weight regain have not been assessed in large scale studies.

The aim of this study is to determine the effect of a low-carbohydrate (CHO) ketogenic diet, compared with an isocaloric balanced diet, on the maintenance of weight loss. The secondary aim is to investigate the impact of both diets on appetite. Adults with obesity (30\<BMI\<40 kg/m2), will first undergo 4 weeks of a very-low energy diet aimed at inducing 5-10% weight loss and then will be randomized to two different weight maintenance diets for 1 year. One will be a low-CHO ketogenic diet (50 g CHO/day) plant-based (e.g. with less animal protein and more plant-based), and the other a diet following the Norwegian Health Directorate recommendations. Only conventional foods will be used in both diets.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • weight stable over the last three months (<2 kg)
  • not currently dieting to lose weight
  • inactive lifestyle (less than 150 min of physical activity weekly.
  • Given that some of the variables of interest have been shown to be affected by the phase of menstrual cycle in normally ovulating women, namely appetite and resting metabolic rate, only women taking oral contraceptives, with regular menstrual cycles or post-menopausal will be included in the study
Exclusion Criteria
  • pregnancy
  • breast-feeding
  • drug or alcohol abuse within the last two years
  • clinically significant illness including diabetes, gastrointestinal (particularly cholelithiasis), kidney (GFR <60) or liver disease, osteoporosis (T-score <-2.5) and osteopenia (T-score <-1.5)
  • treatment with antiosteoporotic drug
  • depression or other psychological disorders
  • eating disorders
  • milk intolerance
  • current medication known to affect appetite/metabolism or induce weight loss.
  • a planned surgery during the study period
  • participating in another research study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Isocaloric balanced weight loss maintenance dietIsocaloric balanced weight loss maintenance dietThe isocaloric balanced weight loss maintenance group will undergo in a diet following the standard Norwegian Health Directorate recommendations for 1 year.
Ketogenic weight loss maintenance dietKetogenic weight loss maintenance dietThe ketogenic weight loss maintenance group will undergo in a ketogenic diet (50 g CHO/day) plant-based for 1 year.
Primary Outcome Measures
NameTimeMethod
Body weight regainBody weight changes at 1-year intervention

Body weight will be measured at baseline, at week 5, at 6 months, and at 1 year

Secondary Outcome Measures
NameTimeMethod
Fasting lipid profileLipid profile changes at 1-year intervention

Blood sampling in fasting to measure lipid profile (plasma concentration of total cholesterol, triglycerides, high-density lipids (HDL), low-density lipids (LDL) at baseline, at 6 months, and at 1 year

Bone mineral densityBone mineral density changes at 1-year intervention

Bone mineral density will be measured by Dual-energy X-ray absorptiometry (DXA) at baseline, at 6 months, and at 1 year

Trial Locations

Locations (1)

Forsyningssenteret at NTNU

🇳🇴

Trondheim, Norway

© Copyright 2025. All Rights Reserved by MedPath